Healthcare provider profile · identity verified

Marsha Alexander, M.D.

Family Practice · VACAVILLE, CA · NPI 1275692055

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	557	75
Amlodipine Besylate	Amlodipine Besylate	298	43
Levothyroxine Sodium	Levothyroxine Sodium	260	32
Losartan Potassium	Losartan Potassium	244	32
Gabapentin	Gabapentin	205	37
Metoprolol Succinate	Metoprolol Succinate	204	31
Tamsulosin Hcl	Tamsulosin Hcl	192	27
Pantoprazole Sodium	Pantoprazole Sodium	167	27
Furosemide	Furosemide	154	32
Duloxetine Hcl	Duloxetine Hcl	142	21
Lisinopril	Lisinopril	136	23
Metformin Hcl	Metformin Hcl	126	16
Eliquis	Apixaban	125	23
Famotidine	Famotidine	115	20
Clopidogrel	Clopidogrel Bisulfate	112	15
Carvedilol	Carvedilol	106	18
Mirtazapine	Mirtazapine	101	13
Trazodone Hcl	Trazodone Hcl	97	13
Trulicity	Dulaglutide	96	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	95	14
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	85	13
Buspirone Hcl	Buspirone Hcl	85	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	82	22
Omeprazole	Omeprazole	75	suppressed
Finasteride	Finasteride	71	12
Jardiance	Empagliflozin	70	11
Hydrochlorothiazide	Hydrochlorothiazide	69	suppressed
Montelukast Sodium	Montelukast Sodium	69	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	67	11
Insulin Lispro Kwikpen U-100	Insulin Lispro	66	11
Metoprolol Tartrate	Metoprolol Tartrate	66	12
Rosuvastatin Calcium	Rosuvastatin Calcium	61	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	55	suppressed
Propranolol Hcl	Propranolol Hcl	53	suppressed
Bupropion Xl	Bupropion Hcl	52	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	51	32
Divalproex Sodium	Divalproex Sodium	51	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	51	suppressed
Citalopram Hbr	Citalopram Hydrobromide	50	suppressed
Potassium Chloride	Potassium Chloride	48	11
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	46	46
Memantine Hcl	Memantine Hcl	44	suppressed
Sertraline Hcl	Sertraline Hcl	43	11
Ezetimibe	Ezetimibe	42	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	41	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	40	suppressed
Tramadol Hcl	Tramadol Hcl	40	suppressed
Entresto	Sacubitril/Valsartan	39	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	39	suppressed
Divalproex Sodium Er	Divalproex Sodium	38	suppressed
Fluticasone Propionate	Fluticasone Propionate	37	18
Levetiracetam	Levetiracetam	37	suppressed
Bumetanide	Bumetanide	35	suppressed
Estradiol	Estradiol	35	suppressed
Hydralazine Hcl	Hydralazine Hcl	35	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Lumigan	Bimatoprost	34	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	33	suppressed
Ranolazine Er	Ranolazine	33	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	32	suppressed
Olanzapine	Olanzapine	32	suppressed
Simvastatin	Simvastatin	32	suppressed
Gemtesa	Vibegron	31	suppressed
Latanoprost	Latanoprost	31	suppressed
Clonazepam	Clonazepam	29	suppressed
Midodrine Hcl	Midodrine Hcl	29	suppressed
Paroxetine Hcl	Paroxetine Hcl	29	suppressed
Spironolactone	Spironolactone	29	suppressed
Nifedipine Er	Nifedipine	28	suppressed
Valsartan	Valsartan	28	suppressed
Allopurinol	Allopurinol	27	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	27	27
Pregabalin	Pregabalin	27	suppressed
Donepezil Hcl	Donepezil Hcl	26	suppressed
Mirabegron Er	Mirabegron	26	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	25	suppressed
Meloxicam	Meloxicam	25	suppressed
Pravastatin Sodium	Pravastatin Sodium	25	suppressed
Timolol Maleate	Timolol Maleate	25	suppressed
Alendronate Sodium	Alendronate Sodium	24	suppressed
Aripiprazole	Aripiprazole	24	suppressed
Bupropion Hcl	Bupropion Hcl	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	suppressed
Methotrexate	Methotrexate Sodium	24	suppressed
Baclofen	Baclofen	23	suppressed
Primidone	Primidone	22	suppressed
Tiotropium Bromide	Tiotropium Bromide	21	suppressed
Insulin Aspart Flexpen	Insulin Aspart	20	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	19	suppressed
Insulin Degludec Pen (U-200)	Insulin Degludec	19	suppressed
Lorazepam	Lorazepam	19	suppressed
Rybelsus	Semaglutide	19	suppressed
Tradjenta	Linagliptin	19	suppressed
Buprenorphine Hcl	Buprenorphine Hcl	18	suppressed
Cephalexin	Cephalexin	18	suppressed
Linzess	Linaclotide	18	suppressed
Prazosin Hcl	Prazosin Hcl	18	suppressed
Prednisone	Prednisone	18	11
Xarelto	Rivaroxaban	18	suppressed
Glipizide	Glipizide	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Testosterone	Testosterone	16	suppressed
Amiodarone Hcl	Amiodarone Hcl	15	suppressed
Betimol	Timolol	15	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	15	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Prolia	Denosumab	15	suppressed
Trintellix	Vortioxetine Hydrobromide	15	suppressed
Ultra-Fine Original Pen Needle	Pen Needle, Diabetic	15	suppressed
Vyzulta	Latanoprostene Bunod	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Creon	Lipase/Protease/Amylase	14	suppressed
Insulin Lispro	Insulin Lispro	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	12	suppressed
Dexlansoprazole Dr	Dexlansoprazole	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Torsemide	Torsemide	12	suppressed
Clozapine	Clozapine	11	suppressed
Erythromycin	Erythromycin Base	11	suppressed
Invega Sustenna	Paliperidone Palmitate	11	suppressed
Lacosamide	Lacosamide	11	suppressed
Prednisolone Acetate	Prednisolone Acetate	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed
Zolmitriptan Odt	Zolmitriptan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error